AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.

Revenue
+6.03%
EPS
−73.9%
Free cash flow
−16.9%
Total debt
+14.6%

Quarter to September 2026, against a year earlier

143.84 3.02 −2.06%
Market cap
$9.1B
P/E
34.6×
Fwd P/E
25.9×
Dividend yield
1.00%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100

AptarGroup, Inc. (ATR) Shares outstanding

Alert me on Shares outstanding

AptarGroup, Inc.'s shares outstanding at the end of fiscal 2025 was $66.7M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $64.1M. Over the past ten years it has ranged from $64.5M (fiscal 2015) to $67.7M (fiscal 2024); the current reading is higher than 73% of that period. AptarGroup, Inc. ranks 23rd of 47 Medical Instruments & Supplies companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $66.7M (1.43%)
FY2024 $67.7M 1.17%
FY2023 $66.9M 0.28%
FY2022 $66.7M (1.42%)
FY2021 $67.7M 1.54%
FY2020 $66.7M 0.77%
FY2019 $66.2M 1.84%
FY2018 $65.0M 0.56%
FY2017 $64.6M (0.39%)
FY2016 $64.8M 0.55%

Quarterly newest first

Period Shares outstanding Change
Sep 2026 $64.1M (0.10%)
Jun 2026 $64.2M (0.97%)
Mar 2026 $64.8M (2.83%)
Dec 2025 $66.7M 0.14%
43 more quarters

Against its own ten years

Low $64.5M High $67.7M
Ten-year median $66.7M
Current reading's percentile 73

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on ATR